ALLMedicine™ Venous Thromboembolism Center
Research & Reviews 8,109 results
https://doi.org/10.1093/ptj/pzac057
Physical Therapy; Hillegass E, Lukaszewicz K et. al.
May 15th, 2022 - No matter the practice setting, physical therapists work with patients who are at risk for or who have a history of venous thromboembolism (VTE). In 2016, the first clinical practice guideline (CPG) addressing the physical therapist management of ...
https://doi.org/10.1007/s00520-022-07096-1 10.1007/s11239-015-1311-6 10.1634/theoncologist.2015-0361 10.1200/JCO.2005.03.8877 10.1182/blood.2020007338 10.1160/TH16-08-0615 10.1007/s00520-018-4602-6 10.1007/s00520-021-06598-8 10.1007/s11912-019-0767-5 10.1007/s12272-017-0976-0 10.1038/bjc.2013.48 10.1177/2047487319891780 10.1007/s11548-010-0526-4 10.1161/01.CIR.0000122870.22669.4a 10.1634/theoncologist.2013-0239 10.1016/j.blre.2019.03.005 10.1111/jth.15367 10.1016/s1470-2045(13)70579-5 10.1177/1758835918818347 10.1007/s10637-012-9878-7 10.1007/s40262-020-00930-x 10.4172/2155-9864.1000202 10.1200/JCO.2014.58.7550 10.1002/phar.2213 10.1007/s00520-017-4034-8 10.3892/etm.2019.8019 10.3389/fneur.2018.01067 10.1038/s41416-019-0510-x 10.1182/asheducation-2018.1.339 10.3322/caac.21654 10.3322/caac.20073 10.1097/JTO.0b013e31811ea275 10.1038/bjc.2016.143 10.1378/chest.13-2379 10.1111/j.1538-7836.2010.03929.x 10.1016/j.thromres.2019.11.009 10.1159/000046586 10.1200/JCO.2009.22.3271 10.1111/j.1538-7836.2004.00928.x 10.1002/cncr.21496 10.1038/s41416-018-0027-8 10.1111/jth.13752 10.1001/jama.293.6.715 10.1001/archinte.164.2.190 10.1161/ATVBAHA.120.314378 10.1177/1358863X14568705 10.1182/blood-2018-99-116439 10.4103/jcrt.JCRT_121_18 10.21873/anticanres.13954 10.1200/JCO.19.01461 10.1007/s00520-017-3990-3 10.1007/s00432-016-2131-6 10.5114/wo.2013.33766 10.1093/ajhp/58.17.1614 10.3892/ol.2022.13235 10.1177/1076029617729215 10.1007/s00520-012-1590-9 10.1016/j.thromres.2014.02.020 10.3892/ijo.2014.2803 10.1056/NEJMoa1108898 10.1016/S1470-2045(09)70232-3 10.31887/DCNS.2011.13.2/npatsopoulos
Supportive Care in Cancer : Official Journal of the Multi... Xynogalos S, Simeonidis D et. al.
May 14th, 2022 - Patients with active cancer have a 4-sevenfold increased risk for venous thromboembolism (VTE) especially during systematic anticancer treatment. Simultaneously, surgery is an additional risk factor. The Metaxas's Hospital THromboprophylaxis progr...
https://doi.org/10.1111/jth.15758
Journal of Thrombosis and Haemostasis : JTH; Chalayer E, Talbot A et. al.
May 14th, 2022 - Venous thromboembolism (VTE) is a concern for patients with newly diagnosed multiple myeloma. We aimed to evaluate VTE incidence, risk factors and risk score. We performed a substudy of the 'Intergroupe Francophone du Myelome 2009' randomized cont...
https://doi.org/10.1007/s11239-022-02661-1 10.1377/hlthaff.28.5.w822 10.1016/j.ejvs.2006.10.006 10.1016/j.amjmed.2005.03.012 10.1016/j.chest.2015.11.026 10.1007/s11239-020-02179-4 10.1016/S2352-3026(19)30086-9 10.1177/1060028019886092 10.1016/j.thromres.2019.08.021 10.1183/23120541.00554-2020 10.1007/s11239-020-02238-w 10.1007/s11239-020-02361-8 10.1007/s11239-020-02199-0 10.1155/2020/3890706 10.1111/ejh.13471 10.7759/cureus.10006 10.1002/pds.2109 10.2147/CEOR.S205597 10.1080/03610910902859574 10.1056/NEJMoa1007903 10.1056/NEJMoa1113572 10.1001/archinte.168.15.1678 10.1007/s40256-020-00434-w 10.1186/1472-6963-14-70 10.1177/0163278714553661 10.1002/pds.4617 10.1080/03007995.2019.1666448
Journal of Thrombosis and Thrombolysis; Berger JS, Laliberté F et. al.
May 14th, 2022 - Prior observational studies suggest rivaroxaban is safe and effective among patients with morbid obesity who suffered a venous thromboembolism (VTE) event, but existing data are more limited in the broader population of VTE patients with obesity. ...
https://doi.org/10.1186/s12879-022-07421-3 10.1016/j.thromres.2020.04.024 10.1016/S2352-3026(20)30145-9 10.1016/j.thromres.2020.08.022 10.1016/j.jacc.2020.05.001 10.1001/jama.2020.12839 10.1056/NEJMoa2015432 10.1111/jth.15463 10.1016/S0140-6736(20)30566-3 10.1136/bmj.m1328 10.1111/acem.13992 10.1001/jama.2021.4152 10.1016/j.chest.2020.05.559 10.1016/j.thromres.2020.04.013 10.1016/j.thromres.2020.04.041 10.1111/jth.14869 10.1371/journal.pone.0248029 10.1055/a-1366-9656 10.1093/cid/ciab003 10.1111/acem.14096 10.1161/ATVBAHA.120.314779 10.1161/CIRCULATIONAHA.120.047430 10.1007/s11239-020-02202-8 10.1186/s12879-021-05945-8 10.1155/2020/9126148 10.1016/j.thromres.2020.09.017 10.1016/j.jvsv.2021.02.018 10.1002/rth2.12486 10.1177/1358863X21995566 10.1182/bloodadvances.2020003763 10.1001/jamanetworkopen.2021.11788 10.1056/NEJMoa2105911 10.1056/NEJMoa2103417
BMC Infectious Diseases; Lee Y, Jehangir Q et. al.
May 14th, 2022 - Patients with COVID-19 infection are commonly reported to have an increased risk of venous thrombosis. The choice of anti-thrombotic agents and doses are currently being studied in randomized controlled trials and retrospective studies. There exis...
Guidelines 54 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566097
Blood Advances; Cuker A, Tseng EK et. al.
Nov 3rd, 2021 - COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care pr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416320
Blood Advances; Cuker A, Tseng EK et. al.
Sep 3rd, 2021 - COVID-19-related critical illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care...
https://doi.org/10.1016/j.jclinepi.2021.07.010
Journal of Clinical Epidemiology; Morgano GP, Wiercioch W et. al.
Jul 21st, 2021 - The goal of this study was to develop an approach that can be used where baseline risk estimates that are directly applicable to prioritized patient-important outcomes are not available from published studies. The McMaster University GRADE Centre ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903232
Blood Advances; Lyman GH, Carrier M et. al.
Feb 12th, 2021 - Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and mortality. These evidence-based guidelines of the American Society of Hematology (ASH...
https://doi.org/10.1016/j.ygyno.2020.11.020
Gynecologic Oncology; Gressel GM, Marcus JZ et. al.
Dec 2nd, 2020 - Venous thromboembolism (VTE) is a common cause of morbidity and mortality in women with gynecologic malignancies. This practice statement provides clinical data and overall quality of evidence regarding the use of direct oral anticoagulants (DOACs...
Drugs 17 results see all →
Clinicaltrials.gov 215 results
https://clinicaltrials.gov/ct2/show/NCT03080883
May 11th, 2022 - PRIMARY OBJECTIVE: I. Any episode of major bleeding including fatal bleeding or clinically relevant non-major bleeding. SECONDARY OBJECTIVES: I. The proportion of patients who experienced at least one such bleeding event within 6 months of beginni...
https://clinicaltrials.gov/ct2/show/NCT04153760
May 6th, 2022 - The purpose of the pilot PARTUM trial is to determine whether it is feasible to conduct a larger randomized controlled trial to determine whether low-dose aspirin is efficacious and safe at preventing postpartum venous thromboembolism (VTE) in wom...
https://clinicaltrials.gov/ct2/show/NCT05246943
May 2nd, 2022 - This will be a quantitative prospective cohort study conducted at the University of Texas Medical Branch (UTMB) Galveston and League City campuses. Candidates include subjects who will have elective colorectal surgery at UTMB. This study looks to ...
https://clinicaltrials.gov/ct2/show/NCT03915925
Apr 27th, 2022 - The objective of this study is to compare right ventricular dysfunction (RVD)dependent and independent prognostic models for short-term serious adverse events in pulmonary embolism (PE) patients. The target population is emergency department (ED) ...
https://clinicaltrials.gov/ct2/show/NCT05347550
Apr 26th, 2022 - Hospital acquired thrombosis describes blood clots that form in the legs and lungs after someone is treated in hospital. Clots in the leg can cause swelling, pain and other problems. If a clot in the leg travels to the lungs, it may be life threat...
News 1,268 results
https://www.medscape.com/viewarticle/973912
May 12th, 2022 - Core Messages If no triggering event can be identified for a patient with deep vein thrombosis, an unknown cancer should be considered as a cause. Rosemary Poulose and L. Christian Napp, MD, et al from Hannover Medical School in Germany recalled t...
https://www.medscape.com/viewarticle/972800
Apr 27th, 2022 - Venous thromboembolism (VTE) is common in patients with cancer and can increase the risk of dying, as well as interfering with treatment and increasing the cost of treatment. New findings suggest that patients with cancer who have non-O blood type...
https://www.mdedge.com/hematology-oncology/article/254054/breast-cancer/abemaciclibet-shows-manageable-safety-profile-hr
Apr 25th, 2022 - Key clinical point: Adjuvant abemaciclib plus endocrine therapy (ET) showed a manageable and acceptable safety profile in patients with hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2-), high-risk, early breast canc.
https://www.medscape.com/viewarticle/971749
Apr 7th, 2022 - The study covered in this summary was published on MedRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways In a UK Biobank cohort, ambulatory patients with mild COVID-19 were 20 times more likely to develop venous thromboemboli...
https://www.medscape.com/viewarticle/971483
Apr 2nd, 2022 - The antifibrinolytic tranexamic acid (TXA) reduced serious bleeding without a significant effect on major vascular outcomes in patients undergoing noncardiac surgery at risk for these complications in the POISE-3 trial. TXA cut the primary efficac...